Coronavirus vaccine

New Delhi: Pfizer and Moderna’s COVID-19 vaccines have reached neighbouring Pakistan, Bangladesh and Sri Lanka. But their entry to India is still in limbo, as the Central government has not...

European Medicines Agency (EMA) approved Moderna’s COVID-19 vaccine for children aged 12 to 17 years on Friday. The drug regulator of European Union (EU) informed that a study conducted among...

New Delhi: The second dose trial of Bharat Biotech’s COVID-19 vaccine, Covaxin, for children between 2-6 years will begin at the All India Institute of Medical Sciences (AIIMS) in New...

New Delhi: World Health Organization (WHO) South-East Asia Regional Director, Dr Poonam Khetrapal Singh said that WHO had a meeting with Hyderabad-based vaccine maker Bharat Biotech on its dossier for...

New Delhi: The discussions are being held between the Indian government and COVID-19 vaccine manufacturers Moderna and Pfizer over several issues including indemnity waiver, Member (Health), NITI Aayog, Dr VK...

New Delhi: As part of the vaccination trial for children in the age group of 2-6 years, the second dose of Covaxin is likely to be administered next week. A...

New Delhi: Vaccines that aim to curb COVID-19 deaths and hospitalisation in patients substantially including people infected by the highly transmissible delta variant that made India’s second wave devastating and...

New Delhi: As the country waits for a COVID vaccine for children before a possible third wave of the coronavirus pandemic hits India, a senior government official said on Friday...

The Sputnik V vaccine provides enough protection against the Delta strain of coronavirus, a leading Russian scientist has said. That will be welcome news for people in India as it’s...

New Delhi: There is the risk of pre-term delivery if a pregnant woman gets infected by COVID-19, which can affect both the mother and baby, a senior government official said...